Appointments: Bayer, Mustang, Modus, GammaDelta, Poxel, Metrion and Renova.

This week's roundup includes CEO appointments by various companies including Mustang Bio, GammaDelta and Modus Therapeutics and other high-level appointments by Bayer, Renova, Metrion and Poxel.

Bayer AG has appointed Bhavesh Ashar senior vice president and head of oncology for the company's US pharmaceutical division. Ashar was vice president and general manager of US oncology at Sanofi, where he spent over 14 years holding positions of increasing responsibility in sales and marketing. Before Sanofi, he was an engagement manager with McKinsey & Company.

Mustang Bio Inc. has named Manuel Litchman president, CEO and a member of the company’s board of directors. Michael S. Weiss, who oversaw Mustang’s corporate operations on an interim basis, will continue as chair of the board. Litchman joins Mustang from Arvinas Inc., where he was previously president and CEO

More from Executives On The Move

Executives On The Move: Five CEOs, Three CFOs And Two CMOs Among This Week’s Changes

Recent moves in the industry include changes at the top at Immunovant, Zymeworks and Cassava Sciences, among others, plus Zealand Pharma acquires chief scientific officer from Eli Lilly.

Executives On The Move: Ten CMOs And Three CEOs and CFOs Each Among This Week’s Changes

Recent moves in the industry include C-suite changes at Dyne Therapeutics, City Therapeutics and ProQR Therapeutics, plus Madrigal Pharmaceuticals acquires chief medical officer from Novartis.

Executives On The Move: Six CMOs, Five CEOs And Two CSOs Among This Week’s Changes

Recent moves in the industry include C-suite changes at Merck KGaA, Newleos Therapeutics and Artiva Biotherapeutics, plus Valo Therapeutics acquires chief executive officer from Johnson & Johnson.

Executives On The Move: Nine CEOs, Six CMOs And Three CFOs Among This Week’s Changes

Recent moves in the industry include changes at the top at Novo Nordisk and Takeda, plus Nxera Pharma nabs chief commercial officer from AstraZeneca.

More from Leadership